459 related articles for article (PubMed ID: 27564099)
1. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
2. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
[TBL] [Abstract][Full Text] [Related]
3. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
4. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O
Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417
[TBL] [Abstract][Full Text] [Related]
5. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P
Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
[TBL] [Abstract][Full Text] [Related]
7. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer.
Lin KW; Huang AM; Lin CC; Chang CC; Hsu WC; Hour TC; Pu YS; Lin CN
Eur J Pharmacol; 2014 Oct; 740():742-51. PubMed ID: 24933647
[TBL] [Abstract][Full Text] [Related]
9. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines.
Woessmann W; Chen X; Borkhardt A
Cancer Chemother Pharmacol; 2002 Nov; 50(5):397-404. PubMed ID: 12439598
[TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of cancer cell death and reduction of clonogenic resistance by cisplatin and FK228.
Choudhary S; Sood S; Wang HC
Biochem Biophys Res Commun; 2013 Jun; 436(2):325-30. PubMed ID: 23743194
[TBL] [Abstract][Full Text] [Related]
11. Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.
Sang J; Li W; Diao HJ; Fan RZ; Huang JL; Gan L; Zou MF; Tang GH; Yin S
Cancer Lett; 2021 Jul; 509():13-25. PubMed ID: 33836250
[TBL] [Abstract][Full Text] [Related]
12. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
13. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
[TBL] [Abstract][Full Text] [Related]
15. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK.
Jeon ES; Lee MJ; Sung SM; Kim JH
J Cell Biochem; 2007 Apr; 100(6):1536-47. PubMed ID: 17131361
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of bladder cancer by sodium butyrate and cisplatin.
Maruyama T; Yamamoto S; Qiu J; Ueda Y; Suzuki T; Nojima M; Shima H
J Infect Chemother; 2012 Jun; 18(3):288-95. PubMed ID: 22041988
[TBL] [Abstract][Full Text] [Related]
17. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T
J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291
[TBL] [Abstract][Full Text] [Related]
19. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
20. ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway.
Liu J; Ma L; Chen X; Wang J; Yu T; Gong Y; Ma A; Zheng L; Liang H
Tumour Biol; 2016 Jun; 37(6):8181-7. PubMed ID: 26715278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
